Skip to content
  • Saturday, 12 September 2026
  • 6:29 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Advancements in Alzheimer’s Disease Research Highlight Need for Subtype-Specific Treatments and Equitable Access to Diagnostics
Pharmaceutical R&D

Advancements in Alzheimer’s Disease Research Highlight Need for Subtype-Specific Treatments and Equitable Access to Diagnostics

Teuku Ryan Jul 22, 2026 0

The landscape of Alzheimer’s disease (AD) research and treatment is undergoing a significant transformation, marked by the recent advent of…

Read More
Pharmaceutical R&D

Japan Emerges as a Global Powerhouse for Regenerative Medicine Innovation

Teuku Ryan Jul 22, 2026 0

Japan is rapidly solidifying its position as a premier destination for regenerative medicine research and development, a surge driven by…

Read More
Pharmaceutical R&D

Novo Nordisk Sues Eli Lilly Over Alleged Deceptive Advertising of Obesity Drugs

Teuku Ryan Jul 21, 2026 0

The escalating rivalry between pharmaceutical giants Novo Nordisk and Eli Lilly has reached a new legal frontier, with Novo Nordisk…

Read More
Pharmaceutical R&D

AI Can Accelerate Study-Build Foundations, But Only When Teams Combine Targeted Automation with Standards, Traceability and Control.

Teuku Ryan Jul 21, 2026 0

Artificial intelligence (AI) is rapidly transforming various sectors, and clinical data management is no exception. While the potential applications of…

Read More
Pharmaceutical R&D

Samsung Biologics to Acquire PolyPeptide Group for SFr1.46 Billion, Expanding Peptide Therapeutics and CDMO Capabilities

Teuku Ryan Jul 21, 2026 0

Samsung Biologics has announced its intent to acquire PolyPeptide Group, a leading contract development and manufacturing organization (CDMO) specializing in…

Read More
Pharmaceutical R&D

New Therapies Usher in Era of Personalised Treatment for Rare Blood Cancers

Teuku Ryan Jul 21, 2026 0

A significant advancement in the treatment of rare blood cancers is set to transform the lives of approximately 200 patients…

Read More
Pharmaceutical R&D

The Inaugural EU Joint Clinical Assessment: Ojemda Sets Precedent Amidst Access Uncertainties

Teuku Ryan Jul 20, 2026 0

The European Union’s landmark Joint Clinical Assessment (JCA) for Ipsen’s orphan-designated drug Ojemda (tovorafenib) has been published, marking a significant…

Read More
Pharmaceutical R&D

Eli Lilly Acquires AtaiBeckley for $2.8 Billion, Marking Entry into Psychedelic Therapeutics

Teuku Ryan Jul 20, 2026 0

In a landmark move that signals a significant shift in pharmaceutical investment, Eli Lilly and Company has announced the acquisition…

Read More
Pharmaceutical R&D

Novo Nordisk Secures European Approval for Oral Wegovy, Bolstering First-Mover Advantage in Obesity Pill Market

Teuku Ryan Jul 20, 2026 0

Novo Nordisk has solidified its pioneering position in the burgeoning market for oral obesity medications with the European Commission’s marketing…

Read More
Pharmaceutical R&D

UK Recommends Routine Meningitis B Vaccination for Adolescents Following Data Review

Teuku Ryan Jul 19, 2026 0

The UK’s Joint Committee on Vaccination and Immunisation (JCVI) has put forth a significant recommendation for the introduction of a…

Read More

Posts pagination

1 2 3 4 … 33
Science News: A Century of Empowering Public Understanding of ScienceStudy Reveals Artery Widening Not Fatty Plaque as Primary Driver of Lacunar Stroke and Small Vessel DiseaseA Century of Scientific Literacy: The Evolution and Impact of Science News Since 1921Pharma 50 2026: The top spot in pharma rarely lasts. Lilly is betting it can change that.
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetLLMOps in 2026: The 10 Tools Every Team Must Have
Attention Unleashed: Rethinking ADHD as a Conduit for Creative Innovation in the Modern Neurological LandscapeHarmonic Shielding: Harvard Researchers Use Microscopic Sound Waves to Protect Fragile Quantum InformationSolstice Oncology Secures $225m in Series A Financing to Advance Neoadjuvant Immuno-Oncology Therapy PorustobartScience News: A Century of Independent Scientific Journalism and the Evolution of Public Literacy
YOU MAY HAVE MISSED
Neuroscience & Brain Research
Attention Unleashed: Rethinking ADHD as a Conduit for Creative Innovation in the Modern Neurological Landscape
Rifan Muazin Sep 12, 2026
Advanced Materials Science
Harmonic Shielding: Harvard Researchers Use Microscopic Sound Waves to Protect Fragile Quantum Information
Nila Kartika Wati Sep 12, 2026
Pharmaceutical R&D
Solstice Oncology Secures $225m in Series A Financing to Advance Neoadjuvant Immuno-Oncology Therapy Porustobart
Teuku Ryan Sep 12, 2026
Environmental & Analytical Chemistry
Science News: A Century of Independent Scientific Journalism and the Evolution of Public Literacy
Abdurrohim Arsyad Sep 12, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ